Beam Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Beam Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Beam Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Beam Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.3M | 306k | 27.22 |
| 2023-09-30 | $6.7M | 280k | 24.05 |
| 2023-06-30 | $7.2M | 236k | 30.62 |
| 2023-03-31 | $7.2M | 236k | 30.62 |
| 2022-12-31 | $9.7M | 249k | 39.11 |
| 2022-09-30 | $2.8M | 59k | 47.64 |
| 2022-06-30 | $2.5M | 65k | 38.71 |
| 2022-03-31 | $2.6M | 45k | 57.30 |
| 2021-12-31 | $3.2M | 41k | 79.69 |
| 2021-09-30 | $3.4M | 40k | 87.01 |
| 2021-06-30 | $4.9M | 38k | 128.71 |
| 2021-03-31 | $1.5M | 18k | 80.04 |
| 2020-12-31 | $1.1M | 13k | 81.64 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas